about
Common and distinct mechanisms of induced pulmonary fibrosis by particulate and soluble chemical fibrogenic agentsAdipose tissue immunity and cancerTenascin-C: Form versus functionTenascin-C in development and disease of blood vesselsThe LIM-only protein FHL2 attenuates lung inflammation during bleomycin-induced fibrosisRevisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolismRegulation of the innate immune response by fibronectin: synergism between the III-1 and EDA domainsThe MMP-9/TIMP-1 axis controls the status of differentiation and function of myelin-forming Schwann cells in nerve regeneration.Tenascin C promiscuously binds growth factors via its fifth fibronectin type III-like domain.Advances in tenascin-C biology.Elastofibroma dorsi: a histochemical and immunohistochemical studyRevisiting the matricellular concept.Tenascin-C: Exploitation and collateral damage in cancer managementEvaluation of matricellular proteins in systemic and local immune response to Mycobacterium tuberculosis infection.Fibrillin-2, tenascin-C, matrilin-2, and matrilin-4 are strongly expressed in the epithelium of human granular and lattice type I corneal dystrophies.Carbon Monoxide Inhibits Tenascin-C Mediated Inflammation via IL-10 Expression in a Septic Mouse Model.Increased tenascin C and Toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity.Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort studyMatricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localizationRaised circulating tenascin-C in rheumatoid arthritis.Tenascin-C drives persistence of organ fibrosis.The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL.Microenvironment and tumor progression of melanoma: new therapeutic prospectives.Tenascin-C and mechanotransduction in the development and diseases of cardiovascular systemAdvances in Toll-like receptor biology: Modes of activation by diverse stimuli.Environmental preconditioning rejuvenates adult stem cells' proliferation and chondrogenic potential.The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications.Tenascin-C produced by oxidized LDL-stimulated macrophages increases foam cell formation through Toll-like receptor-4.Distinct microenvironmental cues stimulate divergent TLR4-mediated signaling pathways in macrophages.Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.Serum tenascin-C level is associated with coronary plaque rupture in patients with acute coronary syndrome.Toll-Like Receptor-4 Signaling Drives Persistent Fibroblast Activation and Prevents Fibrosis Resolution in Scleroderma.Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers.Novel Tenascin-C Haplotype Modifies the Risk for a Failure to Heal After Rotator Cuff Repair.Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.Tenascin-C, a biomarker of disease activity in early ankylosing spondylitis.Candidate gene approach identifies six SNPs in tenascin-C (TNC) associated with degenerative rotator cuff tears.Anti-Vascular Endothelial Growth Factor Treatment Suppresses Early Brain Injury After Subarachnoid Hemorrhage in Mice.Homeobox a5 Promotes White Adipose Tissue Browning Through Inhibition of the Tenascin C/Toll-Like Receptor 4/Nuclear Factor Kappa B Inflammatory Signaling in Mice.Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease.
P2860
Q23914874-AE7B6997-F807-462A-81EB-82096C46A380Q26862654-896A96D7-7EDC-423D-A6D3-F6BB37ECE969Q27023815-702B8093-C600-424E-AC64-15308DE06355Q27027610-92DF8967-111D-4458-B1CE-286AAF6626CBQ27301282-1F9215A5-AD6E-45C7-A1C6-3D82D2D01272Q28085224-E7D14C46-9232-4B4B-9D95-946F9EF00EEDQ28541049-16D480CB-AD11-44E3-893B-386E409C54E2Q34206417-9EBCABFD-94A0-4EE5-9AD3-229475DD417AQ34700906-7618E663-FB37-4A85-B63A-DFEB602860B5Q35214557-B29B3ABB-35E2-4E32-BCF2-702760695A79Q35228792-EB8D8C57-D1EF-4313-990E-CE99D43DB15BQ35233858-2A45B165-C643-492F-A967-869EB7032E6BQ35577959-245922E6-D002-4EF6-87B4-8812AC9884F0Q35764003-DCCB90AF-C029-4021-B3B8-A0E58FF16D3BQ36146036-47F35564-96A2-4460-B2BF-B8DAE84B8B04Q36198698-17CC6A53-9FB0-4501-AE63-AE288C9B1F99Q36293594-3ED2CD0C-1063-445F-9EC6-A18937547FE6Q36321563-CC2C7017-1E31-48C3-A761-A5D2AA1F1024Q36578825-8A7C0AC4-A283-46AD-A10D-383F3356FC1AQ36907720-DA799E93-52E9-4648-969D-06BB7D03C9F9Q36975903-9233DD93-EBC3-4A4A-B415-B9CCC65B0266Q37052067-47097D89-628A-4C48-A785-8E88C9B43822Q38049368-D7036542-D756-4D79-AF84-C07484CA328CQ38239651-E0BF9404-8492-4E21-84D2-316E7CAC9827Q38413291-0F7D9127-0417-4A26-B990-9CA62EE98C15Q39030766-6B65B245-692A-4B64-93CB-1CA8AEC1B7E8Q39099711-8BCF6B9F-671C-4CEB-BFEC-A948373B0314Q39331170-F0DFC219-FAB6-472C-8BF2-C82DE6981200Q39438851-7BBA0051-124C-4A49-B494-47D1349E7733Q40219277-1542EE91-A15D-451A-9D10-3E0CD798CB82Q44375221-EB2480F8-08A9-4FCB-8935-2F15180DB11CQ47095125-0091E345-9A7F-4CF8-AE80-1B05BB51137DQ47100288-45675445-6A6E-4F42-9601-3380D66CB781Q47627088-6740FC44-2220-4C56-9467-6A721AE41FDAQ49553693-2D6859AC-9C8C-4D56-800C-11470275AE85Q50127590-82401628-CA44-4C83-948D-644DE6BA0A28Q51726607-EAD1C903-5674-47EB-919F-ECF8CD883C4BQ52151011-93232279-1258-4D24-A254-A785243A4930Q52590761-52652EC6-8149-47DD-A7A2-D9AEF179E5D2Q52719312-F09CC6A7-43AD-4068-A187-AF59D3D3D46A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression and immune function of tenascin-C.
@en
Expression and immune function of tenascin-C.
@nl
type
label
Expression and immune function of tenascin-C.
@en
Expression and immune function of tenascin-C.
@nl
prefLabel
Expression and immune function of tenascin-C.
@en
Expression and immune function of tenascin-C.
@nl
P2093
P1476
Expression and immune function of tenascin-C
@en
P2093
Kim S Midwood
Michaela Ruhmann
Scott J P Thomson
P304
P356
10.1615/CRITREVIMMUNOL.V31.I2.30
P577
2011-01-01T00:00:00Z